Haruyasu Murakami
Impact in
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 113
- Lung Cancer Diagnosis and Treatment 31
- Oncology 114
- Lung Cancer Research Studies 46
- Colorectal Cancer Treatments and Studies 22
- Cancer Immunotherapy and Biomarkers 21
- HER2/EGFR in Cancer Research 13
- Co-authors
- Toshiaki Takahashi (180 shared papers)Masahiro Endo (119 shared papers)Tateaki Naito (154 shared papers)Nobuyuki Yamamoto (117 shared papers)Akira Ono (129 shared papers)Hirotsugu Kenmotsu (122 shared papers)Yukiko Nakamura (47 shared papers)Kyoichi Kaira (50 shared papers)
- Journals
- Annals of Oncology (34 papers)Lung Cancer (26 papers)Journal of Thoracic Oncology (21 papers)Cancer Chemotherapy and Pharmacology (18 papers)Investigational New Drugs (16 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Haruyasu Murakami
284 papers receiving 7.3k citations
Haruyasu Murakami's Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 3.2k
- Pulmonary and Respiratory Medicine 3.4k
- Cancer Research 826
- Neurology 451
- Geriatrics and Gerontology 63
Countries citing papers authored by Haruyasu Murakami
This map shows the geographic impact of Haruyasu Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruyasu Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruyasu Murakami more than expected).
Fields of papers citing papers by Haruyasu Murakami
This network shows the impact of papers produced by Haruyasu Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruyasu Murakami. The network helps show where Haruyasu Murakami may publish in the future.
Co-authors
The 25 scholars most cited alongside Haruyasu Murakami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 293 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials Hit paper breakdown → | 2019 | 398 |
| 2 | 2016 | 261 | |
| 3 | 2011 | 181 | |
| 4 | 2005 | 169 | |
| 5 | 2012 | 168 | |
| 6 | 2020 | 164 | |
| 7 | 2013 | 153 | |
| 8 | 2016 | 152 | |
| 9 | 2014 | 147 | |
| 10 | 2010 | 131 | |
| 11 | 2016 | 130 | |
| 12 | 2006 | 120 | |
| 13 | Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial Hit paper breakdown → | 2024 | 118 |
| 14 | 2011 | 116 | |
| 15 | 2010 | 111 | |
| 16 | 2008 | 84 | |
| 17 | 2011 | 81 | |
| 18 | 2016 | 79 | |
| 19 | 2005 | 75 | |
| 20 | 2011 | 75 |
About Haruyasu Murakami
Haruyasu Murakami is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Neurology, Cancer Research and Epidemiology, having authored 293 papers that have together received 7.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (113 papers), Lung Cancer Research Studies (46 papers), Lung Cancer Diagnosis and Treatment (31 papers), Colorectal Cancer Treatments and Studies (22 papers), Cancer Immunotherapy and Biomarkers (21 papers), Myasthenia Gravis and Thymoma (14 papers), HER2/EGFR in Cancer Research (13 papers) and Neuroendocrine Tumor Research Advances (12 papers). The work is most often cited by research in Oncology (3.2k citations), Pulmonary and Respiratory Medicine (3.4k citations), Cancer Research (826 citations), Neurology (451 citations) and Geriatrics and Gerontology (63 citations). Haruyasu Murakami has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Toshiaki Takahashi, Masahiro Endo, Tateaki Naito, Nobuyuki Yamamoto, Akira Ono, Hirotsugu Kenmotsu, Yukiko Nakamura, Kyoichi Kaira, Asuka Tsuya and Takehito Shukuya. Their work appears in journals such as Annals of Oncology, Lung Cancer, Journal of Thoracic Oncology, Cancer Chemotherapy and Pharmacology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.